Skip to main content
. 2017 Nov 20;8(65):109018–109026. doi: 10.18632/oncotarget.22558

Figure 3.

Figure 3

(A) ROC curve of tumour resolvin D levels. (B) Hierarchical clustering analyses using 25 most statistical significant metabolites significantly different between endometrial cancer tumours with high versus low blood flow (Student’s T-Test, Benjamini Hochberg False Discovery Rate, p<0.05). Unknown identities are represented as exact mass@retention time.